Literature DB >> 9028780

An immunocytochemical study of calpain II in the hippocampus of rats injected with kainate.

W Y Ong1, L J Garey, K K Tan.   

Abstract

The distributions of the kainate/DL-alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid (KA/ AMPA) receptors GluR1 and calcium-activated neutral protease II (calpain II) in the hippocampus of normal and kainate-lesioned rats were studied by immunocytochemistry. There was a reduction in GluR1 immunoreactivity and a slight increase in calpain II immunoreactivity on the dendrites of pyramidal neurons in CA fields affected by the kainate at 18 h postinjection. Calpain II immunore-activity was associated with amyloid fibrils at electron microscopy. These fibrils were most often intracellular, in membrane-bound profiles, some of which were contacted by axon terminals and were identified as degenerating dendrites. There was extensive destruction of mitochondrial membranes in degenerating profiles, and accumulations of amyloid fibrils were often localised in mitochondria in a calpain-positive profile. This was unlike other, calpain-negative degenerating profiles, that contained tubulovesicular profiles or multilamellar bodies, where mitochondrial membranes were preserved. Many more calpain-positive profiles were observed at electron microscopy 6 days after kainate injection. The enzyme was present in macrophages and astrocytes in lesioned areas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9028780     DOI: 10.1007/bf02454147

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  40 in total

1.  Polyclonal antisera specific for the proenzyme form of each calpain.

Authors:  D E Croall; C A Slaughter; H S Wortham; C M Skelly; L DeOgny; C R Moomaw
Journal:  Biochim Biophys Acta       Date:  1992-05-22

2.  Neurofilament disguise, destruction and discipline.

Authors:  D S Gilbert; B J Newby
Journal:  Nature       Date:  1975-08-14       Impact factor: 49.962

3.  An immunoblot study of neurofilament degradation in situ and during calcium-activated proteolysis.

Authors:  W W Schlaepfer; C Lee; V M Lee; U J Zimmerman
Journal:  J Neurochem       Date:  1985-02       Impact factor: 5.372

4.  Proteolytic enzymes in experimental spinal cord injury.

Authors:  N L Banik; E L Hogan; J M Powers; K P Smith
Journal:  J Neurol Sci       Date:  1986-05       Impact factor: 3.181

5.  Changes in polyamine levels and spectrin degradation following kainate-induced seizure activity: effect of difluoromethylornithine.

Authors:  I Najm; G el-Skaf; G Massicotte; P Vanderklish; G Lynch; M Baudry
Journal:  Exp Neurol       Date:  1992-06       Impact factor: 5.330

6.  Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo.

Authors:  R Siman; J C Noszek
Journal:  Neuron       Date:  1988-06       Impact factor: 17.173

7.  Calcium-activated neutral proteinase of human brain: subunit structure and enzymatic properties of multiple molecular forms.

Authors:  A Vitto; R A Nixon
Journal:  J Neurochem       Date:  1986-10       Impact factor: 5.372

8.  Limited autolysis reduces the Ca2+ requirement of a smooth muscle Ca2+-activated protease.

Authors:  D R Hathaway; D K Werth; J R Haeberle
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

Review 9.  Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease.

Authors:  R A Nixon; K I Saito; F Grynspan; W R Griffin; S Katayama; T Honda; P S Mohan; T B Shea; M Beermann
Journal:  Ann N Y Acad Sci       Date:  1994-12-15       Impact factor: 5.691

10.  Effects of in vivo administration of kainic acid on the extracellular amino acid pool in the rabbit hippocampus.

Authors:  A Lehmann; H Isacsson; A Hamberger
Journal:  J Neurochem       Date:  1983-05       Impact factor: 5.372

View more
  1 in total

Review 1.  Kainic Acid-Induced Excitotoxicity Experimental Model: Protective Merits of Natural Products and Plant Extracts.

Authors:  Nur Shafika Mohd Sairazi; K N S Sirajudeen; Mohd Asnizam Asari; Mustapha Muzaimi; Swamy Mummedy; Siti Amrah Sulaiman
Journal:  Evid Based Complement Alternat Med       Date:  2015-12-17       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.